Comparison of goserelin and leuprorelin for ovarian protection during chemotherapy in young patients with breast cancer.
Sung Eun KimWon-Ji KimDoo Seok ChoiDong-Yun LeePublished in: Breast cancer research and treatment (2023)
Goserelin and leuprorelin were comparable in terms of ovarian protection during doxorubicin/cyclophosphamide-based chemotherapy in young patients with breast cancer.